Novo Nordisk

(14 search results)

As semaglutide patent expiry nears, Novo Nordisk partners with Abbott to launch second brand in India
Novo Nordisk plans bigger play in rare diseases segment in India
Novo Nordisk gets USFDA nod for weight loss drug Wegovy as once a day pill
How India is turning out to be global pharma’s battleground for anti-obesity drugs
Novo Nordisk says patent expiry will not dent Ozempic's India market potential
Novo Nordisk slashes price of anti-obesity drug Wegovy as Lilly's Mounjaro sets sales record in India
Pfizer acquires start-up Metsera for $10 billion; know the leaders behind the small biopharma company
Big Pharma’s $10-billion tug-of-war for Metsera: a 3-year-old start-up with no revenues, products
Novo Nordisk's blockbuster drug Ozempic's India launch is imminent, so are its generic versions
Novo Nordisk's obesity drug Wegovy cuts risk of heart attack by 57% vs Eli Lilly’s tirzepatide, shows real-world study